Jayme Eduardo Burmeister

Summary

Affiliation: Porto Alegre
Country: Brazil

Publications

  1. ncbi Topiramate and severe metabolic acidosis: case report
    Jayme E Burmeister
    Serviços de Clínica Médica e de Nefrologia, Hospital Luterano
    Arq Neuropsiquiatr 63:532-4. 2005
  2. ncbi Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis
    Jayme Eduardo Burmeister
    Unidade de Medicina Renal, Hospital Universitario, Universidade Luterana do Brasil, R Alvaro Alvim, 400 90420 020, Porto Alegre, RS, Brazil
    Nephrol Dial Transplant 22:1184-9. 2007
  3. ncbi Rosuvastatin in hemodialysis: short-term effects on lipids and C-reactive protein
    Jayme E Burmeister
    Renal Medicine Unit, Medicine School, Universidade Luterana do Brasil ULBRA, Canoas, Rio Grande do Sul, Brazil
    J Nephrol 22:83-9. 2009
  4. ncbi [Prevalence of diabetes mellitus in chronic renal failure patients under haemodialysis in Porto Alegre, Brazil]
    Jayme Eduardo Burmeister
    Departamento de Clinica Medica, Universidade Luterana do Brasil, Bella Vista, Porto Alegre, RS, Brazil
    J Bras Nefrol 34:117-21. 2012

Detail Information

Publications4

  1. ncbi Topiramate and severe metabolic acidosis: case report
    Jayme E Burmeister
    Serviços de Clínica Médica e de Nefrologia, Hospital Luterano
    Arq Neuropsiquiatr 63:532-4. 2005
    ..Stopping medication was followed by normalization of the acid-base status within five weeks. This infrequent side effect appears unpredictable and should be given careful attention...
  2. ncbi Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis
    Jayme Eduardo Burmeister
    Unidade de Medicina Renal, Hospital Universitario, Universidade Luterana do Brasil, R Alvaro Alvim, 400 90420 020, Porto Alegre, RS, Brazil
    Nephrol Dial Transplant 22:1184-9. 2007
    ..The aim of this study was to evaluate the occurrence of HG in diabetic (DM) and non-diabetic (NDM) end-stage renal failure patients during HD using dialytic solution without and with glucose...
  3. ncbi Rosuvastatin in hemodialysis: short-term effects on lipids and C-reactive protein
    Jayme E Burmeister
    Renal Medicine Unit, Medicine School, Universidade Luterana do Brasil ULBRA, Canoas, Rio Grande do Sul, Brazil
    J Nephrol 22:83-9. 2009
    ..Rosuvastatin calcium has not been studied in patients on dialysis to date. We sought to evaluate the results of rosuvastatin therapy regarding lipids, lipoproteins and a marker of inflammation in hemodialysis patients...
  4. ncbi [Prevalence of diabetes mellitus in chronic renal failure patients under haemodialysis in Porto Alegre, Brazil]
    Jayme Eduardo Burmeister
    Departamento de Clinica Medica, Universidade Luterana do Brasil, Bella Vista, Porto Alegre, RS, Brazil
    J Bras Nefrol 34:117-21. 2012
    ..In Brazil, the available data indicate a lower prevalence, around 27%, even though it is also increasing...